HOME > ARCHIVE
ARCHIVE
- REGULATORY NEWS IN BRIEF
June 13, 2005
- JPMA to Compile Proposals for NHI Price Reform in July
June 13, 2005
- OPIR Report Presents Specific Proposals to Improve Review System
June 13, 2005
- Market for Ethical Drugs Grew 3.5% to \7,345,657 Mil. in FY2004: IMS Japan
June 13, 2005
- LDP to Call For Enhancement of Int'l Competitiveness of Pharma Industry
June 13, 2005
- Novartis to Acquire Hexal AG
June 13, 2005
- Committee Recommends Import Approval for Kissei's Salagen
June 13, 2005
- Pfizer Qualitatively and Quantitatively Beefs Up Its Marketing
June 13, 2005
- Council Listens to Industry's Views on How to Strengthen Domestic Industry's Int'l Competitiveness
June 13, 2005
- FY2005 to Be "Milepost" for Teijin Pharm: Mr Ohyagi
June 13, 2005
- PMDA's Activities in FY2004 Wrapped Up
June 13, 2005
- HEALTH FOOD/OTC NEWS IN BRIEF
June 13, 2005
- STATISTICS
June 13, 2005
- MEDICAL DEVICE NEWS IN BRIEF
June 13, 2005
- JMED Approves FY2005 Business Plan
June 13, 2005
- 4 Superpowers Enhance Dominance in Wholesale Industury
June 6, 2005
- Sawai: Growth in Costs Leads to Net Loss
June 6, 2005
- TOPICS 2 articles
June 6, 2005
- Nippon Chemiphar: Sales Growth of 14.8% Driven by Generics
June 6, 2005
- Once-yearly Health Exams Becoming Norm for Housewives
June 6, 2005
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
